Latest News about BNTX
Recent news which mentions BNTX
FDA Approves Pfizer's COVID-19 Booster For Age 12 To 15
January 03, 2022
From Benzinga
Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters
January 03, 2022
From Benzinga
Moderna's on the Rise, but This Small Biotech Is the Nasdaq's Big Winner on New Year's Eve
December 31, 2021
From Motley Fool
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
December 31, 2021
From Motley Fool
Will the Stock Market Crash in 2022?
December 31, 2021
From Motley Fool
Why Pfizer, BioNTech, and Moderna Shot Higher Today
December 30, 2021
From Motley Fool
‘Boosters are critical’: Dr. Fauci and World Health Organization say omicron appears to be milder, but warn it’s still early days
December 30, 2021
From MarketWatch
From Motley Fool
From Benzinga
7 Safe Stocks Immune From Omicron and Future Covid-19 Variants
December 23, 2021
From InvestorPlace
From Benzinga
The Worst Mistake Pfizer Investors Can Make in 2022
December 23, 2021
From Motley Fool
Why BioNTech, Novavax, and Ocugen Stocks Are Slipping Today
December 22, 2021
From Motley Fool
Why Pfizer Stock Is Sinking Today
December 21, 2021
From Motley Fool
3 Great Stocks to Buy With the Omicron Variant Spreading Like Wildfire
December 21, 2021
From Motley Fool
Why Some Coronavirus Stocks Plunged Today
December 20, 2021
From Motley Fool
MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?
December 20, 2021
From InvestorPlace
Data suggests boosters essential to avoid omicron infection, and Fauci says best way to protect kids is make sure adults around them are fully vaccinated
December 20, 2021
From MarketWatch
Dr. Francis Collins, National Institutes of Health outgoing director: ‘Nobody was expecting omicron. This one really was a curveball.’
December 20, 2021
From MarketWatch
3 Biotech Stocks That Soared in 2021 and Could Go Even Higher in 2022
December 19, 2021
From Motley Fool
Can Omicron Variant Antibodies Protect From Other Covid-19 Variants?
December 18, 2021
From Motley Fool
Is This New Data on Valneva's Less-Effective Booster Concerning?
December 18, 2021
From Motley Fool
Why Pfizer and Johnson & Johnson Fell on Friday
December 17, 2021
From Motley Fool
Pfizer Plans To Evaluate Third Shot For Its COVID-19 Vaccine In Kids Below 5 Years
December 17, 2021
From Benzinga
CDC Backs mRNA COVID-19 Vaccines Over Johnson & Johnson's, Citing Higher Rates Of Clotting Cases: Report
December 17, 2021
From Benzinga
Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
December 17, 2021
From Benzinga
Pfizer Submits Application For Approval Of COVID-19 Shot For Adolescents Aged 12 To 15
December 17, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.